Skip to content
  • Facebook
  • Twitter
  • linkedin
  • Instagram
Open Access Publisher of Medical and Social Science Journals
Openventio Publishers
  • Home
  • About us
    • Vision/Mission
    • Open Access
    • Editorial Assessment and Peer Review Process
  • Journals
  • Editorial Guidelines
    • For Authors
    • For Editors
    • For Reviewers
    • For Readers
    • For Librarians
  • Submit Manuscript
  • Contact Us
  • More
    • Advertisement
    • Reprints
    • Privacy Policy
    • FAQs

Volume 3, Issue 2

  • 2017, May

    original research

    Neurofibromatosis Type I and Multiple Gastrointestinal Stromal Tumors: A Unique IdentityOpen Access

    Joana Espiga de Macedo*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-3-117
    PDF328.36 KB 328.36 KB
    Full-Text (HTML)

  • 2017, May

    letter to the editor

    Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases?Open Access

    Vasudeva G. Kamath*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-3-118
    PDF284.49 KB 284.49 KB
    Full-Text (HTML)

  • 2017, June

    mini review

    How Target Therapy can Induce Cardiotoxicity: The Onco-Cardiologist Point of ViewOpen Access

    Joana Espiga de Macedo*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-3-119
    PDF1.21 MB 1.21 MB
    Full-Text (HTML)

  • 2017, July

    editorial

    Dysadherin: A Novel Oncogenic Molecular Biomarker in Oesophageal CancerOpen Access

    Alexandros Charalabopoulos* and Theodoros Liakakos
    DOI: http://dx.doi.org/10.17140/CSMMOJ-3-e005
    PDF350.44 KB 350.44 KB
    Full-Text (HTML)

  • 2017, September

    original research

    Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq DataOpen Access

    Zhengyan Huang, Li Chen and Chi Wang*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-3-120
    PDF897.67 KB 897.67 KB
    Full-Text (HTML)

×

Article in press

NOTE: The DOIs of the In-Press Articles will only function after the final publication of the articles and once they are uploaded to the Current Issues.
×

Current Issue

×

Previous Issue

  • 2020, March

    editorial

    Pathology Hiding in Plain Sight: The NF1 Plasma MembraneOpen Access

    Vincent M. Riccardi*
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-e008
    PDF287.00 KB 287.00 KB
    Full-Text (HTML)

  • 2020, May

    opinion

    Cancer DynamicsOpen Access

    Daniel Gandia* and Cecilia Suárez
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-130
    PDF298.99 KB 298.99 KB
    Full-Text (HTML)

  • 2020, September

    review

    Anastasis: Cell Survival MechanismOpen Access

    Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu
    DOI: http://dx.doi.org/10.17140/CSMMOJ-6-131
    PDF515.40 KB 515.40 KB
    Full-Text (HTML)
    Abstract [+]

    Equilibrium between cell survival and death is important for normal cell homeostasis and development and also for inhibiting pathologies particularly cancer. Anastasis is a natural cell recovery phenomenon that rescues cells from the brink of death or a mechanism by which cells recuperate from apoptotic lesions and return to its normal active and functioning state. Programmed cell death (apoptosis) was known to be an intrinsically irreversible cascade that commits cells to a rapid destruction. However,
    recent studies have demonstrated the possibility of recovering dying cells even at the late stages. Anastasis uses the usual pro-metastatic and pro-survival factors to inhibit apoptotic progression. Epithelial mesenchymal transition (EMT) activation and its related modulators is not only linked with cellular metastasis and survivability but also widely associated with the stemness of cancer cells.
    Keywords
    Anastasis; Programmed cell death; Cancer; Pro-metastatic factor; Pro-survival factor; Genetic instability; Cell cycle arrest.


    • Home
    • Authors Instructions
    • Submit Manuscript
    • Contact Us
    • Editorial Panel
    • Article in press
    • Current issue
    • Previous issue
    • Archive
    • Archive

    Connect with us



    Editor-in-Chief

    Pradeep Garg, PhD


    Executive Director
    Center for Molecular Imaging and Therapy
    Biomedical Research Foundation of Northwest Louisiana
    1505 Kings Highway
    Shreveport, LA 71103, USA

    Associate Editors

    Jennifer Sims-Mourtada, PhD


    Senior Clinical Scientist
    Center for Translational Cancer Research
    Helen F. Graham Cancer Center
    Christiana Care Health System
    Newark, DE, USA

    Our editorial team


    Advertisement

    About Openventio

    Openventio Publishers is licensed under a Creative Commons Attribution 4.0 International License.
    based on the work at www.openventio.org

    Quick Links
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement
    Find Us

    Suite#A, GKS Workspace
    No. 309, 3rd Floor
    RP Business Park
    Shaikpet, Hyderabad
    TS 500008, India

    8280 Willow Oaks Corporate Drive
    Suite 600, Fairfax, VA 22031, USA

     

    Openventio Publishers
    • Facebook
    • Twitter
    • linkedin
    • Instagram
    © 2014 - 2022 Openventio Publishers. All Rights Reserved.
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement